Topics

David Laros is Vice President of Digital Strategy, Analytics and I﻿nsights at 

Articles

Methods that pharma companies can use to make the hub more personalized and experiential. 

Transforming the Patient Hub into a Hub of Patient Centricity

How to provide effective brand engagement in this rocky yet emerging landscape.

Navigating the Biosimilars Marketplace

Matt Wolf, president of biopharma services, Cencora, discusses the importance of partnership in helping to combat prescription drug abandonment and non-adherence.

An Outlook on Data-Powered Patient Support

Study emphasizes role in bridging research and development and commercial/marketing functions.

The Importance of the Medical Affairs Function in Pharmaceutical Companies

Digital twins allow the industry to integrate sustainable practices and supply chain efficiency solutions while ensuring patient safety.

How Digital Twins Drive Sustainability in Clinical Supply Planning

ClearNetwork will be available for a plan sponsor’s list of covered generic, branded, and specialty drugs across 65,000 retail pharmacies in the Express Scripts network.

Major PBM to Offer Cost-Based Pricing Option for Prescription Medications 

New initiative highlights importance of a collaborative approach that allows patients to share their insights and contribute value to studies.

Project Highlights Benefits of Statistical Methodology Research for Patients, Pharma

Financial commitment further strengthens IntegriChain’s platform as a source for pharma manufacturers' commercialization and market access goals.

Nordic Capital Purchases Majority Share in IntegriChain

Conference session discusses the drivers, practical considerations, success factors, and landscape for next-generation pharmacy innovation.

Access Insights 2023: The Pharmacy of the Future 

Bill Roth provides insight as to how where chief commercial officers and access leaders can plan for a profitable product lifecycle. 